A brief overview of clinical significance of blood group antibodies

1. Storry JR, Castilho L, Chen Q, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and terminology: report of the Seoul and London meetings. Vox Sang 2016;11:118–22.10.1111/voxs.12280566201029093749 Search in Google Scholar

2. Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N. The clinical significance of blood group antibodies. Transfus Med 2002;12:287–95.10.1046/j.1365-3148.2002.00399.x12383334 Search in Google Scholar

3. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58–71.10.1016/j.tmrv.2006.08.00317174221 Search in Google Scholar

4. Hendrickson JE, Tormey CA. Red blood cell antibodies in hematology/oncology patients: interpretation of immunohematologic tests and clinical significance of detected antibodies. Hematol Oncol Clin North Am 2016;30:635–51.10.1016/j.hoc.2016.01.00627113001 Search in Google Scholar

5. Tormey CA, Stack G. The characterization and classification of concurrent blood group antibodies. Transfusion 2009;49:2709– 18.10.1111/j.1537-2995.2009.02337.x19682334 Search in Google Scholar

6. Naik R. Warm autoimmune hemolytic anemia. Hematol Oncol Clin North Am 2015;29:445–53.10.1016/j.hoc.2015.01.00126043384 Search in Google Scholar

7. Brodsky RA. Complement in hemolytic anemia. Blood 2015;126:2459–65.10.1182/blood-2015-06-64099526582375 Search in Google Scholar

8. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev 2008;22:1–15.10.1016/j.blre.2007.08.00217904258 Search in Google Scholar

9. Berentsen S, Randen U, Tjonnfjord GE. Cold agglutinin-mediated autoimmune hemolytic anemia. Hematol Oncol Clin North Am 2015;29:455–71.10.1016/j.hoc.2015.01.00226043385 Search in Google Scholar

10. Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother 2015;42:287–93.10.1159/000439002467832026696796 Search in Google Scholar

11. Worel N. ABO-mismatched allogeneic hematopoietic stem cell transplantation. Transfus Med Hemother 2016;43:3–12.10.1159/000441507 Search in Google Scholar

12. The Notify Library: the global vigilance and surveillance database for medical products of human origin. Available from www.notifylibrary.org. Accessed 15 February 2017. Search in Google Scholar

13. Klein HG, Anstee DJ. Immunology of red cells. In: Mollison’s blood transfusion in clinical medicine. 12th ed. Hoboken, NJ: John Wiley & Sons, 2014:53–117. Search in Google Scholar

14. Winters JL, Pineda AA, Gorden LD, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41:1413–20.10.1046/j.1537-2995.2001.41111413.x Search in Google Scholar

15. Delaney M, Wendel S, Bercovitz RS, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016;388:2825–36.10.1016/S0140-6736(15)01313-6 Search in Google Scholar

16. U.S. Food and Drug Administration. Fatalities reported to the FDA following blood collection. 2015. Available from https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/default.htm. Accessed 15 November 2016. Search in Google Scholar

17. The 2015 Annual SHOT Report. Available from https://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked.pdf. Accessed 15 November 2016. Search in Google Scholar

18. Agence nationale de sécurité du médicament et des produits de santé. Rapport d’activité hémovigilance 2015. Available from http://ansm.sante.fr/. Accessed 15 November 2016. Search in Google Scholar